treatment via various energy-based (e.g., laser, microwave, ultrasound, radiofrequency, thermal, etc.) technologies to destroy diseased tissue, cauterize blood vessels for hemostasis, create lesions in myocardium to preempt errant electrical signals in arrhythmia and other purposes.
The European market for ablation technologies shows considerable variation by modality and country, given the differences in adoption rates for the different modalities, the local practice patterns and other regional variations. Below is illustrated the distribution of the ablation market by modality across the major markets in Western Europe. Source: MedMarket DIligence, LLC; Report #A145, [...]
Ablation technologies are a growth medtech field driven as much by physicians pursuing larger caseload as manufacturers developing innovative technologies, according to a new global report from MedMarket Diligence. (PressMethod) – Surgical procedures focus on a wide range of clinical endpoints — the creation of a lesion to block aberrant cardiac rhythms, the destruction of [...]
The largest application for energy-based ablation devices is in cancer therapy, primarily using the radiation therapy modality. Following that is general surgery with its use of electrocautery and electrosurgical devices, RF ablation, cryotherapy, etc. Cardiovascular is thought to be third, even though cardiovascular is making the most noise in the medical press with RF and [...]
Technologies that destroy tissue for therapeutic benefit are collectively known as ablation technologies. By a wide range of energy types or other mechanical methods, they are used to destroy, excise or otherwise treat tissue for therapeutic benefit, from the radiation of cancer, the destruction of the endometrial lining of the uterus causing endometriosis, the creation [...]
Asia-Pacific is a mix of a powerhouse country (Japan), a developing country with enormous market potential (China), a developing country with an arguably much smaller market potential (India), and a country that is more like the European Union in terms of healthcare spend (Australia). Japan is the second largest market for medical devices after the [...]
Cryotherapy is an exciting modality within the energy-based ablation device market, and is set to explode during the next ten years. It is being used primarily in cardiovascular, general surgery, cancer therapy and gynecology, and a good part of its use is thought to be off-label. Cryotherapy was little used in the EU until just [...]
Radiofrequency ablation devices work by sending alternating current through the tissue. This creates increased intracellular temperatures and localized interstitial heat. When temperatures exceed 60°C, cell proteins rapidly denature and coagulate, resulting in a lesion. The lesion can be used to resect and remove the tissue or to simply destroy the tissue, leaving the ablated tissue [...]
The global market for ablation technologies is characterized, like many medtech markets, by a dominance of revenues in western economies. There are nonetheless distinct patterns in the share of ablation by modality from one geography to the next. Below is a simple representation of the global ablation market by major region and modality (aggregated from [...]
The global market for Energy-based Ablation Devices in 2009 was estimated to be about $9,891.2 million. Ablation is considered to be a therapeutic destruction and sealing of tissue and are readily segmented by technology: Electrical Radiation Light Radiofrequency Ultrasound Cryotherapy Thermal (other than cryotherapy) Microwave Hydromechanical Well established technologies like radiation and laser are giving [...]
Below is a listing (condensed from report #A145) of the specific primary applications indicated by manufacturers for the use of radiofrequency (RF) ablation embodied in their devices. As is apparent, RF ablation has penetrated the breadth of medical specialties due to its long history, its facile integration in the practices of a wide range of [...]
Contact:
